Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences. [PDF]
Kalkowska DA +6 more
europepmc +1 more source
Development of a Quantitative One-Step RT-PCR Method for the Detection of Sabin 2 Virus Contamination in a Novel Oral Poliovirus Vaccine Type 2. [PDF]
Manukyan H +6 more
europepmc +1 more source
Assessing the mucosal intestinal and systemic humoral immunity of sequential schedules of inactivated poliovirus vaccine and bivalent oral poliovirus vaccine for essential immunization in Bangladesh: An open-label, randomized controlled trial. [PDF]
Snider CJ +11 more
europepmc +1 more source
[Vaccine-associated poliomyelitis: safety of the oral poliovirus vaccine, Brazil, 2013-2023Poliomielitis asociada a poliovirus derivados de la vacuna: seguridad de la vacuna oral contra la poliomielitis en Brasil, 2013-2023]. [PDF]
Silva RMA +14 more
europepmc +1 more source
Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic. [PDF]
Rivera Mejía L +11 more
europepmc +1 more source
Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization. [PDF]
Sarnquist C +15 more
europepmc +1 more source
Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial. [PDF]
Ochoge M +20 more
europepmc +1 more source

